Celcuity (CELC) Competitors $53.07 -2.00 (-3.63%) Closing price 04:00 PM EasternExtended Trading$52.83 -0.24 (-0.45%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELC vs. GH, RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, PRVA, and VCYTShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include Guardant Health (GH), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Celcuity vs. Its Competitors Guardant Health RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Veracyte Celcuity (NASDAQ:CELC) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Which has more volatility & risk, CELC or GH? Celcuity has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Does the media favor CELC or GH? In the previous week, Guardant Health had 13 more articles in the media than Celcuity. MarketBeat recorded 21 mentions for Guardant Health and 8 mentions for Celcuity. Guardant Health's average media sentiment score of 0.98 beat Celcuity's score of 0.94 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 11 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, CELC or GH? Celcuity has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCelcuityN/AN/A-$111.78M-$3.45-15.38Guardant Health$828.85M8.34-$436.37M-$3.35-16.54 Do analysts rate CELC or GH? Celcuity presently has a consensus target price of $56.50, suggesting a potential upside of 6.46%. Guardant Health has a consensus target price of $58.24, suggesting a potential upside of 5.12%. Given Celcuity's higher possible upside, equities research analysts plainly believe Celcuity is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Celcuity 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Guardant Health 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.06 Is CELC or GH more profitable? Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -49.93%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets CelcuityN/A -150.07% -64.67% Guardant Health -49.93%N/A -28.95% Do institutionals and insiders hold more shares of CELC or GH? 63.3% of Celcuity shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 15.8% of Celcuity shares are owned by insiders. Comparatively, 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryGuardant Health beats Celcuity on 11 of the 16 factors compared between the two stocks. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.25B$3.08B$5.69B$10.27BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-15.3821.3075.8626.51Price / SalesN/A379.77489.92165.26Price / CashN/A44.4425.8129.89Price / Book17.069.6112.846.32Net Income-$111.78M-$53.28M$3.28B$270.51M7 Day Performance-12.67%0.31%0.22%2.15%1 Month Performance2.47%4.58%4.61%6.35%1 Year Performance250.53%9.24%68.33%25.48% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity1.5024 of 5 stars$53.07-3.6%$56.50+6.5%+267.6%$2.25BN/A-15.3840GHGuardant Health3.9302 of 5 stars$60.17+0.1%$58.24-3.2%+104.5%$7.50B$739.02M-17.962,021Insider TradeRDNTRadNet3.4196 of 5 stars$71.99+0.8%$76.80+6.7%+10.6%$5.49B$1.83B-359.9311,021Positive NewsOPCHOption Care Health4.8689 of 5 stars$29.59+1.7%$35.75+20.8%-12.8%$4.72B$5.00B23.678,088Positive NewsSHCSotera Health2.1579 of 5 stars$15.91+1.9%$16.00+0.6%-3.4%$4.44B$1.10B198.903,000High Trading VolumeBTSGBrightSpring Health Services2.2676 of 5 stars$25.48+5.6%$25.67+0.7%+96.2%$4.27B$11.27B82.2035,000High Trading VolumeWGSGeneDx2.5754 of 5 stars$129.33-2.4%$101.63-21.4%+222.3%$3.81B$305.45M2,586.601,200Positive NewsCONConcentra Group Holdings Parent3.0905 of 5 stars$22.79-1.3%$27.50+20.7%-8.0%$2.96B$1.90B19.1511,250Positive NewsSGRYSurgery Partners3.2012 of 5 stars$22.08-1.9%$33.00+49.5%-30.3%$2.89B$3.11B-15.4415,000Positive NewsPRVAPrivia Health Group4.4116 of 5 stars$23.59+1.3%$28.58+21.2%+17.9%$2.86B$1.74B214.471,140Positive NewsVCYTVeracyte3.7619 of 5 stars$32.46+0.1%$40.90+26.0%-3.2%$2.55B$445.76M98.37790Positive News Related Companies and Tools Related Companies Guardant Health Competitors RadNet Competitors Option Care Health Competitors Sotera Health Competitors BrightSpring Health Services Competitors GeneDx Competitors Concentra Group Holdings Parent Competitors Surgery Partners Competitors Privia Health Group Competitors Veracyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELC) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELC Stock Alerts